NCT01520896View on ClinicalTrials.gov

Study in Healthy Volunteers to Investigate the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
BioavailabilityHealthy VolunteersDrug- Drug Interactions
Interventions
DRUG

NKTR-118

Oral 25 mg

DRUG

Ketoconazole

Oral 400 mg

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY